- freely available
Toxins 2012, 4(4), 244-266; doi:10.3390/toxins4040244
Abstract: The safety of food and feed depends to a great deal on quality control. Numerous compounds and organisms may contaminate food and feed commodities and thus pose a health risk for consumers. The compound of interest in this review is ochratoxin A (OTA), a secondary metabolite of the fungi Aspergillus and Penicillium. Due to its adverse health effects, detection and quantification are of utmost importance. Quality control of food and feed requires extraction and analysis, including TLC, HPLC, MS, and immunochemical methods. Each of these methods has its advantages and disadvantages. However, with regard to costs and rapidity, immunochemical methods have gained much interest in the last decade. In this review an introduction to immunochemistry and assay design will be given to elucidate the principles. Further, the application of the various formats to the detection and quantification of ochratoxin will be described, including the use of commercially available kits.
Ochratoxins belong to the group of mycotoxins that are produced as secondary metabolites by fungi, in particular Aspergillus and Penicillium. These fungi flourish under special conditions of temperature and humidity. Ochratoxins include ochratoxin A (OTA), ochratoxin B (OTB), ochratoxin C (OTC) and ochratoxin α (OTα), of which OTA is considered the most toxic. They are teratogenic, mutagenic, hepatotoxic, nephrotoxic and immunesuppressive, and thus pose a serious health problem for exposed humans and animals. Because the fungi infest several kinds of crops for human and animal consumption, the metabolites may be present in all kinds of raw agricultural materials, commodities and beverages. Due to their toxic properties regulations for mycotoxins, including ochratoxins, have been established, at this moment in 100 countries and readjusted in the course of time [1,2,3,4]. Consequently, food/feed quality control is extensively performed. Analysis includes the mouse bioassay, TLC, GC, HPLC, MS and various immunochemical methods, generally after extraction of the target compound(s). Conventional analytical methods and extraction methods are beyond the scope of this review and have been described elsewhere [1,5,6,7]. In the present review the focus is on immunochemical methods for OTA analysis. However, because IAC (immunoaffinity chromatography) uses antibody for additional purification and concentration, this technique will also be described herein. Additional reviews covering conventional analytical techniques for mycotoxins, including immunochemical techniques, were published by Krska et al.  and Turner et al. .
The ubiquitous presence of OTA has been assessed in assay investigations and national surveys of raw and processed agricultural and derived products (cereals, food, feed, coffee, wine, beer, juices, cow milk), and the matrix has been taken into account in the development of detection methods [10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30]. Ingestion due to consumption has been deduced from levels found in bodily fluids and tissues in humans and animals [10,19,22,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51]. Monitoring of food/feed for the presence of mycotoxins/OTA and disposal of contaminated products should lower human and animal health risk.
Immunochemical detection methods vary from simple immunoassay to highly sophisticated immunosensors. Because immunochemical methods are principally all based on antibodies, this review starts with an overview of conventional production methods of antibodies, the advantages and disadvantages as well as advanced production of antibodies and fragments thereof. Then the various formats of immunoassays will be discussed, wherein examples for the application in ochratoxin detection will be given, although not exhaustive. For further reference, see the reviews of Zheng (2006)  and Goryacheva et al. (2009)  for immunochemical methods for mycotoxins, including OTA. A review of available immunoassays kits was given by Huybrechts and Tangni (2010) . In order to evaluate the suitability of immunochemical assays, there are several points to consider. First, the antibody/assay should meet the conditions for a reliable analytical method as with any method. For immunochemical methods, ISO norms have been established (ISO 15087). Second, the norms for the presence of the target compounds in the matrix/product to be measured should be taken into account with regard to the detection limit and working range of an assay. Validation of a newly developed immunoassay also requires reference materials, which may be difficult to obtain, especially in the case of highly toxic and/or complex compounds. For OTA in agricultural products such reference materials are available now. In this review the development, design, evaluation and use of immunochemical methods for the detection and/or quantification of OTA are described. Special attention will be given to chemical/synthetic “antibodies”.
The antibody forms the core component of any immunochemical method, because it is the element that recognizes and binds its target compound (antigen). Antibodies are components of the immune system of animals that defend the body against intruding substances and organisms. They are produced by specialized cells of the immune systems and they comprise several forms: IgA, IgD, IgE, IgG, IgM, IgY (avian). The predominant form secreted in blood is IgG and this form is generally used in immunochemistry. The production of antibodies starts with the immunization of experimental animals, such as rat, rabbit, mouse, sheep, horse, goat, chicken. To be able to raise an immune reaction, the injected compound (immunogen) has to meet several conditions: >1000 Dalton, foreign for the body and with a 3-dimensional structure. In the case of a small compound (hapten), such as ochratoxin, the particular compound is generally coupled to an immunogenic protein, optionally via a spacer group. Coupling proteins include bovine serum albumin (BSA), keyhole limpet hemocyanin (KLH), thyroglobulin (TG), polylysine, among others, although BSA is predominantly used. Coupling procedures are known from literature. Generally, when a hapten belongs to a group of related compounds, the coupling to a carrier protein is performed such that the moiety unique for that hapten is exposed and the carrier protein is bound to another site of the compound. In the case of OTA, the free carboxylic group is commonly used for coupling because of easy chemistry (Figure 1). As will be clear from the section below, this provides antibodies with low cross-reactivity to related compounds. Reversibly, the most resembling mycotoxins OTB (Figure 2) showing sometimes cross-reactivity in OTA immunoassays, provides, when coupled in the same way, antibodies highly specific for OTB .
Immunization involves primary injection of the immunogen, followed by several booster injections. After about 2–6 months the titer (concentration) of the desired antibody is, in general, sufficiently high for use in an assay. The serum of the animal may be used as such, but in most cases the antibodies are isolated and purified with standard methods. Immune serum or purified antibodies are designated polyclonal antibodies (PAb), because they comprise a population of antibodies with different affinities and specificities .
Another widely used production method involves the hybridoma technique [56,57]. Traditionally, the immunogen is used to immunize mice, although nowadays other species are also used. After 2–3 boosters, the spleen is isolated, processed to splenocytes which are fused with myeloma cells, and cultured in limited dilution so that each single antibody producing cell will give rise to a separate cell culture (hybridomas). Then the best performing culture is chosen for mass production and isolation of the antibody. Such antibodies are designated monoclonal antibodies (MAb). In contrast to polyclonal antibodies, monoclonal antibodies consist of one type of antibody with defined affinity and specificity. In addition, monoclonal antibodies can be produced as long as a hybridoma is viable. Sometimes monoclonal antibodies are less stable than polyclonal antibodies.
Alternative forms of antibodies include recombinant antibodies, phage displayed antibodies, plant antibodies, and antibodies fragments that have retained their antigen binding domain. For production methods and properties, there have been published numerous articles and reviews [58,59,60,61,62]. However, these have until now not been used for the development of immunoassays for OTA.
Once an antibody has been obtained, it has to be characterized with regard to specificity and affinity for use in an assay to be suitable for the detection of its target compound. Importantly, in order to have high specificity in an assay, the properties of the antibody with regard to cross-reactivity to related compounds should be determined in subsequent assays. Closely related compounds comprise OTB, OTC, OTD, OTα, coumarin, OH-coumarin. Because of the small size of these compounds, they fit into the binding pocket of the antibody and their common moieties (epitope, binding part) may lead to more or less affinity for the antibody and thus cross-reactivity. Due to a completely different structure, other mycotoxins that are often found on and/or in crops as co-toxins generally will show no cross-reactivity and thus no interference in an immunoassay.
3. Immunoassay Formats
The immunochemical reaction, i.e., the binding of antibody and antigen, in an assay is not visible and therefore several means to detect the reaction product, the immune complex, have been developed based on signal-generating components and appropriate measuring devices. The various immunoassays are named based on the signal-generating component or tracer.
3.1. RIA (Radioimmunoassay)
The first immunoassays made use of a radioactive tracer consisting of the target compound incorporated with a radionuclide, such as 3H, 14C, 125I, although other radionuclides may also be used. The principle of a RIA is the competition between labeled and unlabeled compound for a limited number of binding sites on the antibody. The more unlabeled target compound in a sample, the less tracer is bound to the antibody and radioactivity counting yields a measure for the concentration of target compound in a sample, based on a series of standards. It will be appreciated that 3H and 14C will hardly influence the physic-chemical properties of the tracer and its behavior will hardly change, in contrast to 125I, which is a larger moiety. In order to be able to count only the radioactivity of the immune complex, a separation step is needed. For small compounds, dextran coated charcoal has often been used to perform this separation, followed by centrifugation. Larger target compounds in complex with their binding antibody may be separated using e.g., PEG, followed by centrifugation. An alternative separation method is the use of equilibrium dialysis (ED) where only the free fraction is passing a membrane.
In earlier days, ochratoxin was analyzed by RIA using polyclonal antibodies in several formats. For example, Aalund et al. (1975)  used OTA-bovine IgG as an immunogen to produce polyclonal antibodies and 125I-ovalbumin-OTA as a tracer, followed by a precipitation step. The detection limit was 20 µg/L, which is quite high. This may be due to the large difference between the tracer that includes ovalbumine, a relatively large protein, and OTA itself. The use of 3H-OTA as a tracer in combination with ED for separation of bound and free fraction, was described by Chu et al. (1976) . Here the detection range was from 1–20 ng/mL. Rousseau et al. (1985)  developed a 14C-based RIA in combination with a polyclonal antibody for the detection of OTA in barley. The detection limit was 0.5 ng/mL and the antibody was rather specific for OTA, showing low cross-reactivity with related compounds. In a further study this group also analyzed OTA in serum with a detection limit of 0.4 ng/mL . A 125I-based RIA kit was used by Fukal and Reisnerova (1990)  to assess the ingestion of OTA by humans by measuring OTA in serum (detection limit 100 ng/L). Their conclusion was that OTA is actually ingested and present in serum. Fukal (1990)  reported that, based on measurements using the same kit, food and feed may contain OTA, but it was not detected in porcine kidney.
Due to health hazards of radiolabeled compounds and specialized waste disposal, RIA has not been in use for a long time. Advanced immunochemical methods included various alternative tracers and recently even label-free methods.
3.2. EIA (Enzyme Immunoassay)/ELISA (Enzyme-Linked Immuno Sorbent Assay)
A great advancement in immunoassay was the replacement of radionuclides by enzymes in combination with a substrate that is converted into a detectable colored product. There are many examples of possible enzymes, but HRP (Horse Radish Peroxide) and ALP (Alkaline Phosphatase) are used predominantly. The development of EIA was accompanied by the application of solid supports such as plastic reaction tubes or microtiter plates whereon immunoreagents are coated and the immunochemical reaction is performed (ELISA). After the reaction, the supernatant solution containing unbound fraction is discarded and the signaling enzyme reaction is performed. In such formats the steps of adding separation means and centrifugation are avoided, which shortens the assay time.
ELISA may be designed in various formats. The simplest formats are the direct competitive ELISA (dcELISA) and indirect competitive ELISA (icELISA). The former involves the coating of antibody onto the walls of a tube or microtiter plate, adding standard/sample, followed by antibody and tracer. After incubation, the reaction solution is discarded and the enzyme reaction is performed, which is analyzed with spectrophotometry. In the icELISA the hapten, generally coupled to a carrier protein, is coated onto the support, standard/sample is added, followed by labeled antibody. Further reaction steps are similar to the dcELISA. Between the reaction steps extensive washing is included.
There exist various variants of this kind of enzyme immunoassay, such as the icELISA wherein a secondary antibody raised against the primary antibody, for example, anti-rabbit IgG for polyclonals or anti-mouse IgG for monoclonals, is labeled. Secondary antibody may also be used as a first coating layer to capture primary antibody, where the reaction takes place. Further alternative formats are described in literature and the reader is referred to a recent review .
ELISA has been the preferred method to detect and quantify OTA in raw products, food, feed, beverages, bodily fluids and tissues to assess its presence and concentration for either exposure risks, quality control and as a measure of ingestion and accumulation. Table 1 provides some data found in literature. Formats used for OTA other than ELISA are discussed in further sections below.
|1981||PAb 1||dc||buffer||25 pg||cr|||
|1988||MAb 1||ic||barley||5 µg/kg||−|||
|1989||MAb 1||ic||various||50 pg/mL||+|||
|1990||MAb 1||dc||barley||1 ng/mL||+|||
|1991||MAb 1||dc||barley||1 ng/mL||+|||
|1996||MAb 1||dc||cereals||0.5 ng/g||+|||
|1996||MAb 1||dc||buffer||45 pg/mL||cr|||
|1997||MAb 1||dc||serum||0.2 ng/mL||+|||
|1998||MAb 1||dc||plasma||4–20 pg/mL||−|||
|1999||MAb 2||m||wheat||0.4 ng/mL||+/−|||
|2000||MAb 1||ic||chilies||5 ng/mLa||+|||
|2002||MAb 1||dc||plasma/tissue||0.5 ng/g||+|||
|2002||MAb 2||m||coffee||4 µg/kg||cr|||
|2006||MAb 1||ic||coffee||50 pg/mL||+|||
|2007||MAb 1||ic||coffee||3.73 ng/g||+|||
|2007||PAb 1||m/dc||chilies||10 µg/kg||+|||
|2007||PAb 1||dc||various||1 ng/mL||+/−|||
|2011||PAb 1||str||grains||1.5 µg/kg||+|||
|2011||MAb 1||ic||cereals||1.70 ng/mL a||−|||
1 = produced in-house; 2 = commercial; m = membrane; ic = indirect competitive; dc = direct competitive; str = strip test; a = IC50; cr = only cross-reactivity; + = validated; − = not validated; +/− = partially validated.
In-house production of antibodies is a tedious procedure and requires facilities that are not available to each lab. For the development of an immunoassay commercially available PAb or MAb may be used. Although ELISA is basically a simple analytical method that does not require highly trained technicians, the development, design and validation does. Therefore, as an alternative, immunochemical analysis may be performed with commercial ELISA kits. Use of an ELISA kit for the analysis of wheat flour (Turkey) revealed that 83% of the samples contained OTA . An OTA ELISA kit in combination with an IAC kit was validated for analysis of OTA in wine. The detection limit was 0.054 µg/L, working range 0.25–9 µg/L; the recovery 94–102%; and results compared good with HPLC. A survey of the presence of mycotoxins in herbs (Spain) using commercial IAC columns and ELISA kits with a detection limit for OTA of 0.025 µg/kg showed that 99% of the samples were contaminated .
Although somewhat less toxic, OTB is quite similar to OTA and is often a co-contaminant. To be able to detect OTB in the same samples, a MAb and an ELISA were developed by Heussner et al. (2007) . The same strategy as for OTA was used, i.e., coupling of carrier proteins to the carboxylic moiety. A detection limit of 27 nM was reported, with low cross-reactivity (3.3%) for OTA.
3.3. Sandwich ELISA
For larger target compounds containing several epitopes, the sandwich ELISA is a convenient format. Herein the solid support is coated with one antibody raised to one epitope of the compound; target compound is added, followed by a second antibody raised against another epitope of the compound. Second antibody may be labeled or a third labeled antibody may be used for detection. Because OTA has a low molecular mass and fits into the binding pocket of antibody, there is no further moiety exposed for binding of second antibody. However, a sandwich ELISA system has been developed to detect several molds (Aspergillus, Penicillium, Fusarium) simultaneously by using monoclonal antibodies against the extracellular polysaccharide of these species . Interestingly, Punyatong et al. (2003)  described a sandwich ELISA using two monoclonal antibodies produced in-house with OTA-HSA as immunogen. The developed ELISA, one MAb coated on microtiter plate and one HRP-labeled MAb, showed 50% binding at 35 pg/assay, which is quite sensitive. No further validation or application has been described.
3.4. Chemiluminenscent Immunoassay (CL-IA)
Some samples show high matrix effects in EIA and dilution may be a means to eliminate them. However, that means that the assay should be more sensitive. According to Yu et al. (2011)  a CL-IA may offer an elegant solution. They designed an assay using soy bean peroxidase in combination with luminol and an enhancer (3-(10'-phenothiazinyl)propane-1-sulfonate/4-morpholinopyridine) and they achieved a limit of detection (LOD) of 0.01 ng/mL and a working range of 0.02–0.3 ng/mL in several agricultural products. When samples were compared to a direct competitive ELISA, it appeared that in some samples being negative in the ELISA, OTA could be detected. These CL-IA results were comparable to those of Qui (2010) . Herein an indirect CLIA with HRP-labeled secondary antibody provided a simple, fast and sensitive screening assay for corn samples with an LOD of 0.04 µg/kg.
3.5. Fluorescent Immunoassay (FIA)
Fluorescent immunoassays are a variant of immunoassays, wherein the tracer contains a fluorofore as a label. The advantage of fluorofores is their broad range of excitation and emission wave lengths and availability. However, FIA requires special equipment and microtiter plates (black or white), and care should be taken to avoid background fluorescence interference. The design of FIAs may be direct (labeled hapten), indirect (labeled primary antibody and with labeled secondary antibody. Although simple FIA has not been used for analytical purposes, there exist some variant FIA, which are described below.
3.5.1. Time-Resolved Fluorescent Immunoassay (TR-FIA)
The characteristic of TR-FIA is the use of fluorofores with a longer fluorescence life time, which eliminates background fluorescence and thus enables a more sensitive and specific assay . This technique forms the core in Delphia immunoassays , but many other formats and applications are possible. The use of lanthanide labels in TR-FIA with luminescence detection has been reviewed by Hagan and Zuchner (2011) . In addition, when using two different labels, multi-analyte immunoassay is feasible. An example of mycotoxins detection has been given by Huang et al. (2009)  who developed a TR-FIA for OTA and Aflatoxin B1 (AFL B1) using Sm and Eu as a label, respectively. In this format, antigen-protein was coated onto microtiter plates, then sample and antibody (MAb for OTA and PAb for AFL B1) were added, followed by differently labeled second antibody. This TR-FIA was validated and showed a detection limit for OTA of 0.05 µg/L (range 0.05–50 µg/L) and for Aflatoxin B of 0.02 µg/L (range 0.02–100 µg/L).
3.5.2. Fluorescence-Polarization Immunoassay (FP-IA)
Another variant fluorescent immunoassay is FP-IA. The principle of this technique has been given in a review of Maragos (2009) , including a table showing results from literature for mycotoxins. In short, the binding of a hapten to its antibody is detected by measuring the change in tumbling motion of the particular fluorofore resulting in a change in observed polarization. The solution containing the immunoreagents is exposed to plane-polarized light and the emission light is separated by a vertical and horizontal polarizer. The advantage of FP-IA is that the complete assay is performed in solution, avoiding washing and separation of bound and free fraction. An example of the application of FP-FIA can be found in a publication of Zezza et al. (2009) . This group measured OTA in red wine using both their own and a commercial MAb. The assay was validated with spiked samples and compared to IAC/HPLC. A detection limit of 0.7 ng/mL (below the EU norm of 2.0 ng/mL) was achieved.
3.5.3. FRET (Fluorescence Resonance Energy Transfer) Immunoassay
The technique of separation-free, homogeneous FRET immunoassay is described by Kreissig et al. (2011) . Such an assay uses electronic excited state energy transfer. Both the tracer and the antibody are labeled with a fluorescent tag, a donor and an acceptor respectively. When binding occurs fluorescence is quenched, but displacement by the target compound eliminates this quenching and fluorescence can be measured. A FRET assay, wherein the binding of OTA to its antibody is detected, was developed by Li et al. (2011) . After optimizing reaction conditions, an LOD of 1 ng/mL was achieved, comparable to other immunoassay formats and a commercial kit. There was no cross-reactivity with OTB and the recovery in spiked wheat samples was around 100%.
3.5.4. Fluorescent Micro-Array Immunoassay
An alternative immunoassay format for OTA has been described by Ngundi et al. (2005) . Here a pretreated glass slide is functionalized with NeutrAvidin. OTA-biotine conjugate is patterned onto the slide and then sample plus labeled (Cy5, fluorescent) antibody (PAb, commercial) are reacted by addition through flow channels. After the immunochemical reaction the slide is analyzed by fluorescence CCD imaging. The detection limit varied from 3.8–100 ng/g for various samples of cereals, macaroni, coffee and wine. A feasibility study into the development of a multi-analyte rapid screening microarray device was described by Lamberti (2009) . Herein the presence of both aflatoxin B1 and fumonisin B1 could be detected on BSA-conjugates bound to functionalized (co-polymer) glass slides. This design holds promise for future adaptation to include other mycotoxins, including OTA.
3.6. Lateral Flow Immunoassay (LF-IA)
Rapid screening of samples for contaminants, including OTA, may be performed using lateral flow immunoassay, a form of paper immunochromatography and also called strip tests. A review of the technique was recently reported by Posthuma (2012)  and the application was reviewed by Bazin et al. (2010) .
LF-IA relies on the movement of immunoreagents over a porous material containing pads or lines of target conjugate, sample and antibody, wherein either the target conjugate is labeled or the antibody. The principle of LF-IA is the same as in an EIA. The label may be a chromofore, but nowadays labels consisting of nanoparticles are preferred. The most simple format is the dipstick (mentioned in the reviews of Prieto-Simon and Campas (2009)  and Goryacheva et al. (2009) ). In fact, with haptens as target compounds only the indirect format is feasible. Thus to the porous material are added a hapten-conjugate pad and optionally a test line with secondary antibody, preceded by a release pad and followed by an absorbent pad. Sample and labeled antibody are mixed and added to the release pad and then passed through the porous material by capillary force, competition reaction takes place at the conjugate pad where the signal evaluated visually or measured with appropriate devices.
LF-IA may be designed for multi-analyte detection. For example, using Au-nanoparticles coupled to MAb’s was applied and validated by Shim et al. (2009)  for the detection of both OTA and zearelanone in spiked corn samples. The visual detection limits were 2.5 and 5 ng/mL, respectively. Results were compared to dcELISA and HPLC. A similar LF-IA was developed by Anfossi et al. (2011)  using commercially available PAb that were coupled to Au-nanoparticles. Here nitrocellulose strips were used for application of OTA-BSA lines. Detection of the immunecomplex was performed with a scanner and a detection limit of 0.15 µg/kg of cereal extracts was demonstrated. Results compared very well with LC-FLD.
3.7. Flow-Through Immunoassay
Immunoassays performed in microtiter plates require washing steps and discarding supernatant. To simplify this format, membrane-based immunoassays were developed. Here the antibody is coupled to a membrane attached to a well and the immunochemical reaction using enzyme-labeled antigen/hapten takes place on this membrane. Addition of substrate/chromofore leads to a visible spot on the membrane that may be evaluated visually. It is a rapid, semi-quantitative screening method and kits for OTA are commercially available. Flow-through immunoassay for OTA has been applied by De Saeger and van Pethegem (1999)  using MAb and OTA-HRP. The assay required 15 min of assay time and the detection limit was 0.4 ng/mL. The same working group has validated membrane-based immunoassay kits for OTA and T-2 toxin in a ring test with cereal samples (detection limit for OTA 4 µg/kg, for T-2 toxin 50 µg/kg), wherein the results were compared to HPLC and GC. Comparable results were obtained for OTA in spiked roasted coffee samples by Sibanda et al. (2002) . Their membrane-based assay showed a detection limit of 4 µg/kg and results were confirmed with HPLC in the scope of a patent application.
A recent development of flow-through immunoassay is multi-analyte flow cytometry using the MultaAnalyte Profiling (xMAP) technique in combination with a Luminex apparatus (Austin, TX, USA). Discrimination of analytes is based on color-coded superparamagnetic beads and detection is performed with fluorescent label. The immunochemical reaction occurs in 96-wells microtiter plates, wherein washing and separation steps are performed by application of a magnet. Both a direct and an indirect format were described for the simultaneous detection of OTA and other mycotoxins. In the indirect format the beads a coupled with OTA-conjugate, reacted with sample and antibody or biotinylated antibody. For signal generation, secondary antibody-PE (phycoerythrin) or streptavidin-PE is used, respectively (Peters et al. 2011, Anderson et al. 2010) [100,101]. The detection limits found were in the range of 10–30 ng/g for spiked cereals. A direct format, wherein antibody is coupled to the beads and the reaction is performed by adding sample and OTA-PE conjugate for competition assay is described by Aqai et al. (2011)  and showed a detection limit of 0.15 ng/g. The sensitivity of the Luminex method and multi-analyte mode makes it superior to other immunochemical methods.
Sensors comprise devices for real-time, on-site detection of target compounds. Biosensors use a biomolecule as core component and in immunosensors an antibody is the recognition element, wherein the binding to its cognate ligand leads to a detectable signal. Immunosensors exist of a reaction surface, a transducer and a detector. Transducers may be electrochemical, optical and gravimetric (acoustic wave (AW)/quartz crystal microbalance (QCM)). The techniques have been explained in several reviews [103,104,105,106,107,108]. The most commonly used immunosensors are based on optical transducers and surface plasmon resonance (SPR) is the most known and utilized. Devices generally comprise the Biacore (Uppsala, Sweden) which are available in several embodiments. Even a portable SPR system, the Spreeta, has been mentioned for rapid field mycotoxins analysis . Toxin detection with SPR was reviewed by Hodnik and Anderluh (2009) . Practical application of SPR sensing for OTA was described by Adányi et al. (2007)  for the parallel determination of aflatoxin B1 and OTA in barley and wheat flour samples. The immunochemical format was competition immunoassay with hapten-BSA immobilized on the sensor surface and the use of specific monoclonal antibodies in combination with sample flowing over the surface for measurement. This format revealed a detection range between 0.5 and 10 ng/mL. A similar SPR assay for OTA, but with highly improved sensitivity was reported by Yuan et al. (2009) . They used a new conjugate, OTA-PEG-BSA, for immobilization and Au-nanoparticle coupled monoclonal antibody to achieve much better performance, enabling a range of LODs from 0.058–0.4 ng/mL in cereals and beverages. Second most used immunosensors are based on electrochemical detection. Various parameters for the design of an electrochemical immunosensors for OTA in an indirect format were investigated by Prietó-Simon et al. , such as the coating conjugate (OTA-BSA/avidin-OTA), polyclonal or monoclonal antibody, and enzyme-conjutate (OTA-HRP/OTA-ALP). In the best performing and most stable embodiment a detection limit of 0.7 ng/mL was achieved. In a comparable format using OTA-BSA, monoclonal anti-OTA, but ALP-labeled secondary antibody for detection a very low detection level of 8.2 pg/mL was found . This sensor performed also well in corn samples for matrix effects. A direct format in an electrochemical immunosensors using polyclonal antibody on a modified gold electrode in conjunction with OTA-HRP provided a detection limit of 12 ng/mL . Recently, an electrochemical competitive immunosensor with a detection limit of 0.10 ng/mL for OTA, validated using certified wheat samples, was described by Vidal et al. (2011) . Performance was improved by using OTA-BSA on Au-nanoparticles on the sensor surface, biotinylated monoclonal antibody as binding component and extravidin-HRP for signal generation. An even lower detection limit, 60 pg/mL, was achieved by Urusov et al. (2011)  by signal enhancement due to use of second antibody-colloidal gold particle conjugate. The application of magnetic nanoparticles (MNP), which show various advantages in terms of surface area, stability of bound antibodies, improved orientation of the antibodies and fast assay kinetics, was described by Zamfir et al. . The design comprised a gold surface containing several layers of self-assembling monomers, BSA and MNPs coated with MAb. Detection was performed with both electrochemical impedance spectroscopy (EIS) and SPR, providing a detection limit of 0.01 ng/mL and 0.94 ng/mL, respectively. Results of the assay of spiked white wine were compared to ELISA.
5. Synthetic/Chemical Antibodies
A rather new development in binding chemistry and assays comprises synthetic or chemical “antibodies”, such as MIPs (molecularly imprinted polymers) and aptamers (single-stranded oligonucleotides). MIPs are synthetic polymers with selectivity and specificity for a particular target compound. They are synthesized by mixing target compound and (vinyl) monomers in suspension and then perform polymerization, followed by removal of the target compound. What remains are structures that can specifically harbor the target compound and may be used as alternatives to antibodies in the same applications. The synthesis of MIPs is illustrated in a review of Whitcombe and Vulfson (2001) . A comparison between MIPs and antibodies is given by Lavignac et al. (2004) , indicating affinities of MIPs being lower than of antibodies, but having the advantage of assays to be performed in non-aqueous conditions. They also describe the characterization of radio-molecularly, fluoro-molecularly enzyme-linked molecularly imprinted sorbent assays for a range of small compounds, including non-immunogenic analytes. The application of MIP-based solid phase extraction (MIP-SPE) for environmental pollutants from water, soil and tissues, as well as MIP-based sensors combined with various transduction methods for environmental analytes, including the mycotoxins zearalenone, has been reviewed by Pichon et al. (2008) . Although this technique has not been described for OTA, it is a promising development both for extraction and detection purposes.
Aptamers are another form of chemical binding entities. They are short single-stranded DNA or RNA ligands containing 10–50 variable bases. Aptamers and opportunities for application were discovered already more than 20 years ago. Since that time several reviews have been published about principles and production , signaling in aptamer-based biosensors, also called aptasensors , electrochemical (EC) aptasensors , analytical/pharmaceutical applications [125,126,127], homogeneous assays with aptazymes wherein aptamers regulate the activity of DNA/RNAzymes  and aptasensor with fluorescence detection [129,130]. In practice, having synthesized a DNA or RNA library, aptamers against a particular target are selected by the procedure called SELEX (Systematic Evolution of Ligands by Exponential enrichment). Herein the library is incubated with target, the DNA/RNA-target complex is isolated and eluted and the eluted DNA/RNA is concentrated and amplified. Once a desired aptamer has been obtained, it may be used in formats similar to immunoaffinity columns, immunoassays and immunosensors using comparable sensing techniques. With regard to OTA, an aptamer specific for OTA was applied to an affinity column to capture OTA from wheat sample extracts with known concentration, followed by fluorometric analysis . An ELISA-like enzyme-linked aptamer assay (ELAA) in the direct and indirect format for the detection of OTA was developed by Barthelmebs et al. (2011)  and evaluated for analysis of spiked red wine samples. The method, especially the direct format, compared well to MAb-based direct/indirect ELISA and showed a detection limit of 1 ng/mL with an analysis time of 125 min, which makes it a useful screening method for routine use. Aptasensors for mycotoxins with electrochemical detection were developed by several groups. For example, Kuang et al. (2010)  designed and OTA aptasensor including 3 DNAs, DNA1 for capturing DNA2 (OTA aptamer) on the sensor surface and DNA3 on gold nanoparticles (AuNP) for EC detection using methylene blue for detection of OTA binding to the aptamer and signal amplification. Aptamer coupled to AuNP was used by Bonel et al. (2011)  for EC detection in a competitive assay with OTA-HRP. The sensor was validated with spiked wheat samples and showed a detection limit of 0.07 ng/mL with a range of 0.78–8.74 ng/mL. A different EC aptasensor was described by Tong et al. (2011) . Herein a DNA partly complementary to the OTA aptamer was bound to AuNP for hybridization of the aptamer. Binding of OTA dissociates the aptamer-OTA complex. They achieved a detection limit of 1.0 pg/mL and a range of 0.005–10.0 ng/mL. This aptasensor was validated with spiked and real wheat starch samples in comparison with an ELISA. An aptasensor based on conformational change of aptamer induced by binding of OTA leading to aggregation of the AuNP used for aptamer coupling was described by Yang et al. (2011) . Here a detection limit of 2.5 nM with a range of 20–625 nM was obtained. DNAzyme was applied in the aptasensor developed by Yang et al. (2012) . Binding of OTA to aptamer induced hairpin opening resulting in enzyme activity of HRP-mimicking DNAzyme and oxidation of TMB, which could by measured colorimetrically. Signalling using quantum dots (QD) was applied in a fluorescent strip sensor, wherein QD were conjugated to OTA aptamer and the conjugates applied to strips similar to LF-IA. After the reaction the reading is visually with a limit of detection of 5 ng/mL within 10 min, and 1.9 ng/mL when using Image Analysis Software for a calibration curve in spiked red wine samples. The results were compared to HPLC for confirmation.
6. Immunoaffinity Chromatography
A long used application of antibodies is in immunochromatography for the capture, isolation and/or concentration of target compounds. In this case an antibody is covalently coupled to a solid support (e.g., functionalized agarose, sepharose, silica) and transferred into a column. When sample containing target compound is passed through the column, the target compound will bind to the antibody and may be eluted after washings that remove unwanted matrix components. An elution volume smaller than the sample volume, allows for concentration of the target compound. Commercial IAC columns are available for many target compounds, including OTA, and used as a purification means before further analysis (HPLC, MS, ELISA). A combination of IAC and immunoassay for OTA in one column was developed by the group of van Peteghem (Ghent University) in cooperation with the Saratov State University (Moscow). Initially, the column consisted of a layer of antibody-coupled solid support upon a clean-up layer. OTA-HRP was used for the competitive immunochemical reaction that was detected with TMB and visually evaluated. In samples of roasted coffee  and spices  a cut-off value of 6 µg/kg and 10 µg/mL, respectively, was demonstrated. By using two different antibody containing layers in a similar IAC column both OTA and aflatoxin B1 could be detected in spices . As for the analysis of red wine the cut-off value according to EU legislation is lower than for coffee or spices, the method was optimized to a lower sensitivity (2 µg/L). In this embodiment a separate clean-up column was placed upon a flow-through column containing antibody , and further designed for the simultaneous detection of 2,4,6-trichlorophenol and OTA in red wine or spices [142,143] at a level of 2 µg/L and 10 µg/kg, respectively.
Immunoaffinity extraction in a different setting has been described by Aqai (2011) . Herein monoclonal anti-OTA antibody was coated onto magnetic beads for the capture as well as identification of the target compound in competition with OTA-PE. Detection in wheat and cereal sample extracts was performed by flow cytometry (see above) and compared to LC-MS.
Chemical antibodies have also been used for OTA extraction and analysis. However, due to low recoveries onto MIP, specific extraction had to be preceded by SPE extraction to remove interfering substances. Analysis included LC-MS/MS. Aptamer as selective capturing moiety in an affinity column for the determination of OTA in wheat grain has been described . Analysis of eluted samples was performed with fluorescence spectrometry. Due to the lower affinity in comparison to antibodies, the sensitivity of this method was in the ppb range.
When monitoring for the presence of OTA either in raw and derived agricultural products, there is a large choice of methods. Depending on the purpose, either rapid detection or validation according to the regulations, one can use quantitative and qualitative methods. Among the available conventional methods, HPLC, and among the immunochemical methods, ELISA have traditionally been applied. If performed according to the ISO norms, ELISA may be considered as equipotential to the conventional methods, with comparable sensitivity and the advantage the several samples may be analyzed in the same run. Many researchers have developed and designed in-house antibodies and ELISA. However, commercially available kits have the advantage of avoiding long development which can take a few months. In the course of time there have been successful attempts to improve the ELISA with regard to sensitivity and analysis time. First, the tracer was changed from enzyme plus chromofore to fluorofore. The advantages of using fluorofores are: an improved sensitivity may be achieved; by applying different fluorofores a multi-analyte assay may be designed (TR-FIA); and even homogeneous immunoassays are possible, avoiding washing and separation steps (FP-IA, FRET (label-free)). Disadvantages of fluorescent assays are that background fluorescence may interfere and should be eliminated, and the required equipment is more expensive. Chemiluminescent immunoassay is a variant of ELISA wherein a comparable enzyme is combined with luminol and an enhancer. CL-IA is a rather new technique for OTA detection, but due to a high sensitivity (0.01 ng/mL) and applicability for screening purposes, CL-IA looks promising. Advanced label-free detection methods include biosensors such as SPR (optical) or gravimetric immunosensors, wherein the binding of antigen to antibody is detected by a change in plasmon resonance or mass. SPR may be performed in direct and indirect format and can easily be used for multi-analyte analysis. Improvements include the use of Au-nanoparticles enabling detection limits down to 0.06 ng/mL. Despite the usefulness, SPR equipment is quite expensive. Depending on the number of steps and costs, electrochemical immunosensors may be a good alternative for rapid detection of OTA in various matrices.
Qualitative detection methods include membrane-based immunoassays, lateral flow systems and IAC columns. Each of these is commercially available and may be used for a rapid screening of samples. Reading is visual, although the results may be quantitative when using appropriate devices, such as a scanner. Improvements in strip tests were achieved when using AU-nanoparticles and multi-analyte detection, for example, OTA and zearelanone have been described. Immunoassay on IAC columns is a useful variant of IAC that may be used in the field for both single- and multi-analyte detection. Mycotoxins, including OTA, may be detected at the cut-off level according to EU legislation in different matrices. The advantage of these quantitative methods is the ease and rapidity of performance.
A recent development in analysis includes chemical/synthetic antibodies, MIPs and aptamers. MIPs are polymers forming a kind of binding pocket for a particular target compound. At first, MIPs have proven useful to extraction purposes in SPE-like columns. An MIP for zearelanone applied in a sensor has been described in a review about MIPS for environmental application and production of an MIP-based sensor for OTA is probably only a question of time. Aptamers are oligonucleotides resembling antibodies in selectivity and affinity. They are selected from libraries and used for extraction of OTA, enzyme-linked aptamer assays (ELAA), strip tests, and aptasensors. Improvement of the ELAA by using Au-nanoparticles gave a detection limit of 0.07 ng/mL. Aptasensors show an even lower detection limit of 1.0 pg/mL in wheat samples in an embodiment using partly complimentary DNA. A rapid strip test using quantum dots for labeling of OTA and fluorescent detection showed a detection limit of 5 ng/mL in visual reading and 1.9 ng/mL with a scanner. The assay time in this case was very short (10 min). Aptamers have the advantage that the oligonucleotides, once selected and validated, may be synthesized in large amounts as required.
In conclusion, there is a wide range of immunochemical methods for OTA detection which are widely available or easy to design. Depending on the user’s detection purposes and resources, the most appropriate method may be chosen.
Conflict of Interest
The authors declare no conflict of interest.
- van Egmond, H.P. Methods for determing ochratoxin A and other nephrotoxic mycotoxins. IARC Sci. Publ. 1991, 115, 57–70. [Google Scholar]
- van Egmond, H.P. Analytical methodology and regulations for ochratoxin A. Food Addit. Contam. 1996, 13 (Suppl.), 11–13. [Google Scholar]
- van Egmond, H.P.; Schothorst, R.C.; Jonker, M.A. Regulations relating to mycotoxins in food. perspectives in a global and European context. Anal. Bioanal. Chem. 2007, 389, 147–157. [Google Scholar] [CrossRef]
- Bazin, I.; Nabais, E.; Lopez-Ferber, M. Rapid visual tests: Fast and reliable detection of ochratoxin A. Toxins 2010, 2, 2230–2241. [Google Scholar] [CrossRef]
- Crosby, N.T. Determination of Veterinary Residues in Food; Woodhead Publishing Series in Food Science: Cambridge, UK, 1984; p. 177. [Google Scholar]
- Gilbert, J.; Anklam, E. Validation of analytical methods for determining mycotoxins in foodstuffs. Trends Anal. Chem. 2002, 21, 468–486. [Google Scholar] [CrossRef]
- Shephard, G.S.; Berthiller, F.; Burdaspal, P.; Crews, C.; Jonker, M.A.; Krska, R.; MacDonald, S.; Malone, B.; Maragos, C.; Sabino, M.; et al. Developments in mycotoxins analysis: An update for 2009–2010. World Mycotoxin J. 2011, 4, 3–28. [Google Scholar] [CrossRef]
- Krska, R.; Schubert-Ullrich, P.; Molinelli, A.; Sulyok, M.; Macdonald, S.; Crews, C. Mycotoxin analysis: An update. Food Addit. Contamin. 2008, 25, 152–163. [Google Scholar] [CrossRef]
- Turner, N.W.; Subrahmanyam, S.; Pieletsky, S.A. Analytical methods for determination of mycotoxins: A review. Anal. Chim. Acta 2009, 632, 168–180. [Google Scholar] [CrossRef]
- Fukal, L.; Reisnerova, H. Monitoring of aflatoxins and ochratoxin A in Czechoslovac human sera by immunoassay. Bull. Environ. Contam. Toxicol. 1990, 44, 345–349. [Google Scholar]
- Jorgensen, K.; Rasmussen, G.; Thorup, I. Ochratoxin A in Danish cereals 1986–1992 and daily intake by the Danish population. Food Addit. Contam. 1996, 13, 95–104. [Google Scholar] [CrossRef]
- Ominski, K.H.; Frohlich, A.A.; Marquardt, R.R.; Crow, G.H.; Abrahmson, D. The incidence and distribution of ochratoxin A in western Canadian swine. Food Addit. Contam. 1996, 13, 185–198. [Google Scholar] [CrossRef]
- Valenta, H.; Goll, M. Determination of ochratoxin A in regional samples of cows milk from Germany. Food Addit. Contam. 1996, 13, 669–676. [Google Scholar] [CrossRef]
- Zimmerli, B.; Dick, R. Ochratoxin A in table wine and grapejuice: Occurrence and risk assessment. Food Addit. Contam. 1996, 13, 655–668. [Google Scholar] [CrossRef]
- Scudamore, K.A.; Hetmanski, M.T.; Nawaz, S.; Naylor, J.; Rainbird, S. Determination of mycotoxins in pet foods sold for domestic pets and wild birds using linked-column immunoassay clean-up and HPLC. Food Addit. Contam. 1997, 14, 175–186. [Google Scholar] [CrossRef]
- Thellmann, A.; Weber, W. Bestimmung von Ochratoxin A in Getreide, Malz und Bier nach Anreicherung und Separation an Immunaffinitätssäulen und anschließender Hochleistungflüssigkeitschromatographie mit Fluoreszenzdetektion. Deutsche Lebensmittel-Rundschau 1997, 93, 1–3. [Google Scholar]
- Skaug, M.A. Analysis of Norwegian milk and infant formulas for ochratoxin A. Food Addit. Contam. 1999, 16, 75–78. [Google Scholar] [CrossRef]
- Pietri, A.; Bertuzzi, T.; Pallaroni, L.; Piva, G. Occurrence of ochratoxin A in Italian wines. Food Addit. Contam. 2001, 18, 647–654. [Google Scholar]
- Thuvander, A.; Paulsen, J.E.; Axberg, K.; Johansson, N.; Vidnes, A.; Enghardt-Barbien, H.; Trygg, K.; Lund-Larsen, K.; Jahn, S.; Widenfalk, A.; et al. Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem. Toxicol. 2001, 39, 1145–1151. [Google Scholar] [CrossRef]
- Belli, N.; Marin, S.; Sanchis, V.; Ramos, A.J. Review: Ochratoxin A (OTA) in wines, musts and grapejuices: Occurrence, regulations and methods of analysis. Food Sci. Technol. Int. 2002, 8, 325–335. [Google Scholar]
- Fazekas, B.; Tar, A.K.; Zomborszki-Covács, M. Ochratoxin A contamination of cereal grains and coffee in Hungary in the year 2001. Acta Vet. Hungarica 2002, 50, 177–188. [Google Scholar] [CrossRef]
- Rizzo, A.; Eskola, M.; Atroshi, F. Ochratoxin A in cereals, foodstuffs and human plasma. Eur. J. Plant Pathol. 2002, 108, 631–637. [Google Scholar] [CrossRef]
- Lombaert, G.A.; Pellaers, P.; Roscoe, V.; Mankotia, M.; Neil, R.; Scott, P.M. Mycotoxins in infant cereal foods from the Canadian retail market. Food Addit. Contan. 2003, 20, 494–504. [Google Scholar] [CrossRef]
- Battilani, P.; Magan, N.; Logrico, A. European research on ochratoxin A in grapes and wine. Int. J. Food Microbiol. 2006, 111, S2–S4. [Google Scholar] [CrossRef]
- Aydin, A.; Gunsen, U.; Demirel, S. Total aflatoxin, aflatoxin B1 and ochratoxin A levels in Turkish wheat flour. J. Food Drug Anal. 2008, 16, 48–53. [Google Scholar]
- Martins, H.M.; Marques, M.; Almeida, I.; Guerra, M.M.; Bernardo, F. Mycotoxins in feedstuffs in Portugal: An overview. Mycotoxin Res. 2008, 24, 19–23. [Google Scholar] [CrossRef]
- Flajs, D.; Domijan, A.M.; Ivic, D.; Svjetkovic, B.; Peraica, M. ELISA and HPLC analysis of ochratoxin A in red wines of Croatia. Food Control 2009, 20, 590–592. [Google Scholar] [CrossRef]
- Fujii, S.; Ono, E.Y.S.; Fungaro, M.H.P.; Itano, E.N.; Oliviera, T.C.R.N.; Prete, C.E.C.; Taniwaki, M.H.; Kawamura, O.; Ueno, Y.; Hirooka, E.Y. Indirect competitive ELISA for ochratoxin A detection in coffee and molecular identification of ochratoxin A producing Aspergillus strains. In Mycotoxins and Phycotoxins: Advances in Determination, Toxicology and Exposure Management; Njapau, H., Trujilo, S., van Egmond, H., Park, D., Eds.; Wageningen Academic Press: New York, NY, USA, 2009; pp. 61–71. [Google Scholar]
- Prieto-Simon, B.; Campas, M. Immunochemical tools for mycotoxins detection in food. Monatsh. Chem. 2009, 140, 915–920. [Google Scholar] [CrossRef]
- Santos, L.; Marin, S.; Sanchis, V.; Ramos, A.J. Screening of mycotoxins multicontamination in medicinal and aromatic herbs sampled in Spain. J. Sci. Food Agric. 2009, 89, 1802–1807. [Google Scholar] [CrossRef]
- Breitholz, A.; Olsen, M.; Dahlbäck, A.; Hult, K. Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit. Contam. 1991, 8, 183–192. [Google Scholar] [CrossRef]
- Turconi, G.; Guarcello, M.; Livieri, C.; Comizzoli, S.; Maccarini, L.; Castelazzi, A.M.; Pietri, A.; Piva, G.; Roggi, C. Evaluation of xenobiotics in human milk and ingestion by the newborn. An epidemiological survey in Lombardy (Northern Italy). Eur. J. Nutr. 1994, 43, 191–197. [Google Scholar]
- Micco, C.; Miraglia, M.; Brera, C.; Corneli, S.; Ambruzzi, A. Evaluation of ochratoxin A level in human milk in Italy. Food Addit. Contam. 1995, 12, 351–354. [Google Scholar] [CrossRef]
- Miraglia, M.; de Dominicis, A.; Brera, C.; Corneli, S.; Cava, E.; Menghetti, E.; Miraslia, E. Ochratoxin A levels in human milk and related food samples: An exposure assessment. Nat. Toxins 1995, 3, 436–444. [Google Scholar] [CrossRef]
- Solti, L.; Salamon, F.; Barna-Vetro, I.; Gyöngyösi, A.; Szabo, E.; Wölfling, A. Ochratoxin A content of human sera determined by a sensitive ELISA. J. Anal. Toxicol. 1997, 21, 44–48. [Google Scholar]
- Gareis, M.; Märtlbauer, E.; Bauer, J.; Gedek, B. Bestimmung von Ochratoxin A in Muttermilch. Zeitschr. Lebensm. Forsch. 1988, 186, 114–117. [Google Scholar]
- Jimenez, A.M.; Lopez de Cerain, A.; Gonzalez-Penas, E.; Bello, J.; Betbeder, A.N.; Creppy, E.E. Exposure to ochratoxin A in Europe: Comparison with the region of northern Spain. Toxin Rev. 1998, 17, 479–491. [Google Scholar] [CrossRef]
- Scott, P.M.; Kanhere, S.R.; Lau, B.P.-Y.; Levvis, D.A.; Hayward, S.; Ryan, J.J.; Kuiper-Goodman, T. Survey of Canadian human blood plasma for ochratoxin A. Food Addit. Contam. 1998, 15, 555–562. [Google Scholar] [CrossRef]
- Ueno, Y.; Maki, S.; Lin, J.; Furuya, M.; Sugiura, Y.; Kawamura, O. A four-year study of plasma ochratoxin A in a selected population in Tokyo by immunoassay and immunoaffinity column-linked HPLC. Food Chem. Toxicol. 1998, 36, 445–449. [Google Scholar] [CrossRef]
- Gilbert, J.; Brereton, P.; MacDonald, S. Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit. Contam. 2001, 18, 1088–1093. [Google Scholar] [CrossRef]
- Peraica, M.; Dornijan, A.M.; Matasin, M.; Lucic, A.; Radic, B.; Delas, F.; Horvat, M.; Bosanac, I.; Balija, M.; Grgicevic, D. Variations of ochratoxin A concentration in the blood of healthy populations in some Croatian cities. Arch. Toxicol. 2001, 75, 410–414. [Google Scholar] [CrossRef]
- Skaug, M.A.; Helland, I.; Solvoll, K.; Saugstad, O.D. Presence of ochratoxin A in human milk in relation to dietary intake. Food Addit. Contam. 2001, 18, 321–327. [Google Scholar]
- Chiavaro, E.; Lepiani, A.; Colla, F.; Bettoni, P.; Pari, E.; Spotti, E. Ochratoxin A determination in ham by immunoaffinity clean-up and a quick fluorometric method. Food Addit. Contam. 2002, 19, 575–581. [Google Scholar] [CrossRef]
- Biro, K.; Solti, L.; Barna-Vetro, I; Bago, G.; Glavits, R.; Szabo, E.; Fink-Gremmels, J. Tissue distribution of ochratoxin A as determend by HPLC and ELISA and histopathological effects in chickens. Avian Pathol. 2002, 31, 141–148. [Google Scholar] [CrossRef]
- Filali, A.; Betbeder, A.M.; Baudrimot, I.; Benayada, A.; Soulaymani, R.; Creppy, E.E. Ochratoxin A in human plasma in Morocco: A preliminary survey. Human Exp. Toxicol. 2002, 21, 241–245. [Google Scholar] [CrossRef]
- Stander, M.A.; Steyn, P.S. Survey of ochratoxin A in South African wines. S. Afr. J. Enol. Vitic. 2002, 23, 9–13. [Google Scholar]
- Pacin, A.M.; Ciancio Bovier, E.V.; Motta, E.; Resnik, S.L.; Villa, D.; Olsen, M. Survey of Argentinian human plasma for ochratoxin A. Food Addit. Contam. 2008, 25, 635–641. [Google Scholar] [CrossRef]
- Coronel, M.B.; Marin, S.; Tarragó, M.; Cano-Sancho, G.; Ramos, A.J.; Sanchis, V. Ochratoxin A and its metabolite ochratoxin alpha in urine and assessment of the exposure of inhabitants of Lleida, Spain. Food Chem. Toxicol. 49, 1436–1442.
- Coronel, M.B.; Sanchis, V.; Ramos, A.J.; Marin, S. Ochratoxin A in adult population of Lleida, Spain: Presence in blood plasma and consumption in different regions and seasons. Food Chem. Toxicol. 49, 2697–2705.
- Hooper, D.G.; Bolton, V.E.; Guilford, F.T.; Straus, D.C. Mycotoxin detection in human samples from patients exposed to environmental molds. Int. J. Mol. Sci. 2009, 10, 1465–1475. [Google Scholar] [CrossRef]
- Märtlbauer, E.; Usleber, E.; Dietrich, R.; Schneider, E. Ochratoxin A in human blood serum—Retrospective long-term data. Mycotoxin Res. 2009, 25, 175–186. [Google Scholar] [CrossRef]
- Zheng, M.Z.; Richard, J.L.; Binder, J. A review of rapid methods for the analysis of mycotoxins. Mycopathologia 2006, 161, 261–273. [Google Scholar] [CrossRef]
- Goryacheva, I.Y.; Rusanova, T.Y.; Burmistrova, N.A.; De Saeger, S. Immunochemical methods for the determination of mycotoxins. J. Anal. Chem. 2009, 64, 768–785. [Google Scholar] [CrossRef]
- Huybrechts, B.; Tangni, E. Evaluation of Immunoassay Kits for Ochratoxin A Determination in Cereals; CODA-CERVA Veterinary and Agrochemical Research Center: Tervuren, Belgium, 2010. [Google Scholar]
- Heussner, A.H.; Moeller, I.; Day, B.W.; Dietrich, D.R.; O’Brian, E. Production and characterization of monoclonal antibodies against ochratoxin B. Food Chem. Toxicol. 2007, 45, 827–833. [Google Scholar] [CrossRef]
- Eyer, L.; Franek, M. Production of antibodies for immunoanalytical methods. In Antibodies: Applications and New Developments; Meulenberg, E.P., Ed.; Bentham eBooks: Bussum, The Netherlands, 2012; pp. 29–47. [Google Scholar]
- Köhler, G.; Milstein, C. Continuous cultures of fused cells producing antibody of predefined specificity. Nature London 1975, 256, 495. [Google Scholar]
- Benjouad, A. Antibody biotechnology. Afr. J. Biotechnol. 2009, 8, 2911–2915. [Google Scholar]
- Altshuler, E.P.; Serebryanaya, D.V.; Katrukha, A.G. Generation of recombinant antibodies and means for increasing their affinity. Biochemistry (Moscow) 2010, 75, 1584–1605. [Google Scholar] [CrossRef]
- Huang, L.; Muyldersmans, S.; Saerens, D. Nanobodies: Proficient tools in diagnostics. Exp. Rev. Mol. Diag. 2010, 10, 777–785. [Google Scholar]
- de Muynck, B.; Navarre, C.; Boutry, M. Production of antibodies in plants: Status after 20 years. Plant Biotechnol. J. 2010, 8, 529–563. [Google Scholar] [CrossRef]
- Xie, X.; Richard, G.; Hall, J.C. Antibody fragment engineering and applications in diagnostics and therapies. In Antibodies: Applications and New Developments; Meulenberg, E.P., Ed.; Bentham eBooks: Bussum, The Netherlands, 2012; pp. 225–279. [Google Scholar]
- Aalund, O.; Branfeldt, K.; Hald, B.; Krogh, P.; Poulsen, K. A radioimmunoassay for ochratoxin A: A preliminary investigation. Acta Pathol. Microbiol. Scand. Section C Immunol. 1975, 83C, 390–392. [Google Scholar]
- Chu, F.S.; Chang, F.C.C.; Hinsdill, R.D. Production of antibody against ochratoxin A. Appl. Environ. Microbiol. 1976, 31, 831–835. [Google Scholar]
- Rousseau, D.M.; Slegers, G.A.; van Peteghem, C.H. Radioimmunoassay of ochratoxin A in barley. Appl. Environ. Microbiol. 1985, 50, 529–531. [Google Scholar]
- Rousseau, D.M.; Slegers, G.A.; van Peteghem, C.H. Solid phase radioimmunoassay of ochratoxin A in serum. J. Agric. Food Chem. 1986, 34, 862–865. [Google Scholar] [CrossRef]
- Fukal, L. A survey of cereals, cereal products, feedstuff and porcine kidney for ochratoxin A by radioimmunoassa. Food Addit. Contam. 1990, 7, 253–258. [Google Scholar] [CrossRef]
- Morris, H.A. Standardization of immunoassays. In Antibodies: Applications and New Developments; Meulenberg, E.P., Ed.; Bentham eBooks: Bussum, The Netherlands, 2012; pp. 48–57. [Google Scholar]
- Pestka, J.J.; Steinert, B.W.; Shu, F.S. Enzyme-linked immunosorbent assay for detection of ochratoxin A. Appl. Environ. Microbiol. 1981, 41, 1472–1474. [Google Scholar]
- Candlish, A.A.; Stimson, W.H.; Smith, J.E. Determination of ochratoxin A by monoclonal antibody-based enzyme immunoassay. J. Assoc. Anal. Chem. 1988, 71, 961–964. [Google Scholar]
- Kawamura, O.; Sato, S.; Kajii, H.; Nagayama, S.; Ohtanie, K.; Shiba, J.; Ueno, Y. A sensitive enzyme-linked immunosorbent assay of ochratoxin A based on monoclonal antibodies. Toxicon 1989, 27, 887–897. [Google Scholar] [CrossRef]
- Ramakrishna, N.; Lacey, J.; Candlish, A.A.; Smith, J.E.; Goodbrand, I.A. Monoclonal antibody-based enzyme-linked immunosorbent assay of aflatoxin B1, T-2 toxin and ochratoxin A in barley. J. Assoc. Anal. Chem. 1990, 73, 1–6. [Google Scholar]
- Lacey, J.; Ramakrishna, N.; Candlish, A.A.; Smith, J.E. Immunoassay of ochratoxin and other mycotoxins from a single extract of cereal grains utilizing monoclonal antibodies. IARC Sci. Publ. 1991, 115, 97–103. [Google Scholar]
- Barna-Vetro, I.; Solti, L.; Téren, J.; Gyöngyösi, Á.; Szabó, E.; Wölfling, A. Sensitive ELISA test for determination of ochratoxin A. J. Agric. Food Chem. 1996, 44, 4071–4074. [Google Scholar]
- Barna-Vetro, I.; Solti, L. A new monoclonal antibody detecting ochratoxin A at the pictogram level. Lett. Appl. Microbiol. 1996, 22, 103–105. [Google Scholar] [CrossRef]
- de Saeger, S.; van Peteghem, C. Flow-through membrane-based enzyme immunoassay for rapid detection of ochratoxin A in wheat. J. Food Prot. 1999, 62, 65–69. [Google Scholar]
- Thirumala-Devi, K.; Mayo, M.A.; Reddy, G.; Reddy, S.V.; Delfosse, P.; Reddy, D.V.R. Production of polyclonal antibodies against ochratoxin A and its detection in chilies by ELISA. J. Agric. Food Chem. 2000, 48, 5079–5082. [Google Scholar]
- Sibanda, L.; de Saeger, S.; Barna-Vetro, I.; van Peteghem, C. Development of a solid-phase cleanup and portable rapid flow-through enzyme immunoassay for the detection of ochratoxin A in roased coffee. J. Agric. Food Chem. 2002, 50, 6964–6967. [Google Scholar]
- Fujii, S.; Ono, E.Y.S.; Ribeiro, R.M.R.; Asuncao, F.G.A.; Takabayashi, C.R.; de Oliviera, T.C.R.M.; Itano, E.N.; Ueno, Y.; Kawamura, O.; Hirooka, E.Y. A comparison between enzyme immunoassay and HPLC for ochratoxin A detection in green, roasted and instant coffee. Braz. Ach. Biol. Technol. 2007, 50, 349–359. [Google Scholar]
- Saha, D.; Acharya, D.; Roy, D.; Shrestha, D.; Dhar, T.K. Simultaneous enzyme immunoassay for the screening of aflatoxin B1 and ochratoxin A in chili samples. Anal. Chim. Acta 2007, 584, 343–349. [Google Scholar] [CrossRef]
- Wang, X.H.; Liu, T.; Xu, N.; Zhang, Y.; Wang, S. Enzyme-linked immunosorbent assay and colloidal gold immunoassay for ochratoxin A: Investigation of analytical conditions and sample matrix on assay performance. Anal. Bioanal. Chem. 2007, 389, 903–911. [Google Scholar] [CrossRef]
- Shim, W.B.; Dzantiev, B.B.; Eremin, S.A.; Chung, D.H. One-step simultaneous immunochromatographic strip test for multianalysis of ochratoxin A and zearalenone. J. Microbiol. Biotechnol. 2009, 19, 83–92. [Google Scholar]
- Anfossi, L.; D’Arco, G.; Baggiano, C.; Giovannoli, C.; Gianfranco, G. A lateral flow immunoassay for measuring ochratoxin A: Development of a single system for maize, wheat and durum wheat. Food Control 2011, 22, 1965–1970. [Google Scholar] [CrossRef]
- Zhang, A.; Ma, Y.; Feng, L.; Wang, Y.; He, C.; Wang, X.; Zhang, H. Development of a sensitive competitive indirect ELISA method for determination of ochratoxin A levels in cereals originating from Nanjing, China. Food Control 2011, 22, 1723–1728. [Google Scholar] [CrossRef]
- Kwak, B.Y.; Kwon, B.J.; Kweon, C.H.; Shon, D.H. Detection of Aspergillus, Penicillium, and Fusarium species by sandwich enzyme-linked immunosorbent assay using mixed monoclonal antibodies. J. Microbiol. Biotechnol. 2004, 14, 385–389. [Google Scholar]
- Punyatong, M.; Pongpiachan, P.; Pongpiachan, P. Monoclonal antibodies production and quantification of ochratoxin A in feedstuffs by enzyme-linked immunosorbent assay. Kasetsart J. (Nat. Sci.) 2003, 37, 137–144. [Google Scholar]
- Yu, F.Y.; Vdovenko, M.M.; Wang, J.J.; Sakharov, I.Y. Comparison of enzyme-linked immunosorbent assays with chemiluminescent and colorimetric detection for the determination of ochratoxin A in food. J. Agric. Food Chem. 2011, 59, 809–813. [Google Scholar]
- Qui, Y.Q.; Wang, W.; Li, F.Q. Detection of ochratoxin A in food by chemiluminescent immunoassay. Food Sci. 2010, 31, 432–435. [Google Scholar]
- Hemmilá, I.; Mukkala, V.M. Time-resolution in fluorometry: Technologies, labels, and applications in bioanalytical assay. Crit. Rev. Clin. Lab. Sci. 2001, 38, 441–519. [Google Scholar] [CrossRef]
- PerkinElmer, Delphia® TRF Assays. Available online: www.Perkinelmer.com accessed on 15 February 2012.
- Hagan, A.K.; Zuchner, T. Lanthanide-based time-resolved luminescence immunoassays. Anal. Bioanal. Chem. 2011, 400, 2847–2864. [Google Scholar] [CrossRef]
- Huang, B.; Xiao, H.; Zhang, J.; Zhang, L.; Yang, H.; Zhang, Y.; Jin, J. Dual-label time-resolved fluoroimmunoassay for simultaneous detection of aflatoxin A and ochratoxin A. Arch. Toxicol. 2009, 83, 619–624. [Google Scholar] [CrossRef]
- Maragos, C. Fluorescence polarization immunoassay of mycotoxins: A review. Toxins 2009, 1, 196–207. [Google Scholar] [CrossRef]
- Zezza, F.; Longobardi, F.; Pascale, M.; Eremin, S.A.; Visconti, A. Fluorescence polarization immunoassay for rapid screening of ochratoxin A in red wine. Anal. Bioanal. Chem. 2009, 395, 1317–1323. [Google Scholar] [CrossRef]
- Kreissig, T.; Hoffmann, R.; Zuchner, T. Homogeneous fluorescence-based immunoassay detects antigens within 90 seconds. Anal. Chem. 2011, 83, 4281–4287. [Google Scholar]
- Li, T.; Jeon, K.S. A label-free, direct and noncompetitive FRET immunoassay for ochratoxin A based on intrinsic fluorescence of an antigen and antibody complex. Chem. Comm. 2011, 47, 9098–9100. [Google Scholar]
- Ngundi, M.M.; Shriver-Lake, L.C.; Moore, M.H.; Lassman, M.E.; Ligler, F.S.; Taitt, C.R. Array biosensor for detection of ochratoxin A in cereals in beverages. Anal. Chem. 2005, 77, 148–154. [Google Scholar]
- Lamberti, H.; Tanzarella, C.; Solinas, I.; Padula, C.; Mosiello, L. An antibody-based microarray assay for the simultaneous detection of aflatoxin B1 and fumonisin B1. Mycotox. Res. 2009, 25, 193–200. [Google Scholar] [CrossRef]
- Posthuma-Trumpie, G.A.; van Amerongen, A. Lateral flow assays. In Antibodies: Applications and New Developments; Meulenberg, E.P., Ed.; Bentham eBooks: Bussum, The Netherlands, 2012; pp. 175–183. [Google Scholar]
- Peters, J.; Bienemann-Ploum, M.; de Rijk, T.; Haasnoot, W. Development of a multiplex flow cytometric microsphere immunoassay for mycotoxins and evaluation of its application in feed. Mycotox. Res. 2011, 27, 63–72. [Google Scholar] [CrossRef]
- Anderson, G.P.; Kowtha, V.A.; Taitt, C.R. Detection of fumonisin B1 and ochratoxin A in grain products using microsphere-based fluid array immunoassays. Toxins 2010, 2, 297–309. [Google Scholar] [CrossRef]
- Aqai, P.; Peters, J.; Gerssen, A.; Haasnoot, W.; Nielen, M.W.F. Immunomagnetic microbeads for screening with flow cytocytometry and identification with nano-liquid chromatography mass spectrometry of ochratoxins in wheat and cereal. Anal. Bioanal. Chem. 2011, 400, 3085–3096. [Google Scholar] [CrossRef]
- Sheikh, S.; Blaszykowski, C.; Thompson, M. Acoustic wave-based detection in bioanalytical chemistry: Competition for surface plasmon resonance? Anal. Lett. 2008, 41, 2525–2538. [Google Scholar] [CrossRef]
- Wolfbeis, O.S. Fiber-optic chemical sensors and biosensors. Anal. Chem. 2008, 80, 4269–4283. [Google Scholar] [CrossRef]
- Karyankin, A.A. Biosensors. In Sensors for Environment, Health and Security; Baraton, M.I., Ed.; Springer Science + Business Medi: New York, NY, USA, 2009; pp. 255–265. [Google Scholar]
- Ligler, F.S. Fluorescence-based optical biosensors. In Biophotonics, Biological and Medical Physics, Biomedical Engineering; Pavesi, L., Fauchet, P.M., Eds.; Springer: New York, NY, USA, 2008; pp. 199–215. [Google Scholar]
- Manco, G.; Nucci, R.; Febbraio, F. Use of esterase activities for the detection of chemical neurotoxic agents. Prot. Pept. Lett. 2009, 16, 1225–1234. [Google Scholar] [CrossRef]
- Viswanathan, S.; Radecka, H.; Radecki, J. Electrochemical biosensors for food analysis. Monatsh. Chem. 2009, 140, 891–899. [Google Scholar] [CrossRef]
- van der Gaag, B.; Spath, S.; Dietrich, H.; Stigter, E.; Boonzaayer, G.; van Osenbruggen, T.; Koopal, K. Biosensors and multiple mycotoxin analysis. Food Control 2003, 14, 251–254. [Google Scholar] [CrossRef]
- Hodnik, V.; Anderluh, G. Toxin detection by surface plasmon resonance. Sensors 2009, 9, 1339–1354. [Google Scholar] [CrossRef]
- Adányi, N.; Levkovets, I.A.; Rodriguez-Gil, S.; Ronald, A.; Váradi, M.; Szendró, I. Development of immunosensor based on OWLS technique for determining aflatoxin B1 and ochratoxin A. Biosensors Bioelectr. 2007, 22, 797–802. [Google Scholar] [CrossRef]
- Yuan, J.; Deng, D.; Lauren, D.R.; Aguilar, M.I.; Wu, Y. Surface plasmon resonance biosensor for the detection of ochratoxin A in cereals and beverages. Anal. Chim. Acta 2009, 656, 63–71. [Google Scholar] [CrossRef]
- Prietó-Simon, B.; Campas, M.; Marty, J.L.; Noguer, T. Novel high-performing immunosensors-based strategy for ochratoxin A detection in wine samples. Biosensors Bioelectr. 2008, 23, 995–1002. [Google Scholar] [CrossRef]
- Liu, X.P.; Deng, Y.J.; Jin, X.Y.; Chen, L.G.; Jiang, J.H.; Shen, G.L.; Yu, R.Q. Ultrasensitive electrochemical immunosensors for ochratoxin A using gold colloid-mediated hapten immobilization. Anal. Biochem. 2009, 389, 63–68. [Google Scholar]
- Radi, A.E.; Munoz-Berbel, X.; Cortina-Puig, M.; Marty, J.L. An electrochemical immunosensors for ochratoxin A based on immobilization of antibodies on diazonium-functionalized gold electrode. Electrochim. Acta 2009, 54, 2180–2184. [Google Scholar] [CrossRef]
- Vidal, J.C.; Bonel, L.; Duato, P.; Castillo, J.R. Improved electrochemical competitive immunosensors for ochratoxin A with a biotinylated monoclonal antibody capture probe and colloidal gold nanostructuring. Anal. Meth. 2011, 3, 977–984. [Google Scholar]
- Urusov, A.E.; Kostenko, S.N.; Sveshnikov, P.G.; Sherdev, A.V.; Dzantiev, B.B. Ochratoxin A immunoassay with surface plasmon resonance registration: Lowering limit of detection by the use of colloidal gold immunoconjugates. Sensors Actuat. B. 2011, 156, 343–349. [Google Scholar] [CrossRef]
- Zamfir, L.G.; Geana, I.; Bourigua, S.; Rotariu, L.; Bala, C.; Errachid, A.; Jaffrezic-Renault, N. Highly sensitive label-free immunosensors for ochratoxin A based on functionalized magnetic nanoparticles and EIS/SPR detection. Sensors Actuat. 2011, 159, 178–184. [Google Scholar] [CrossRef]
- Whitcombe, M.J.; Vulfson, E.N. Imprinted polymers. Adv. Mater. 2001, 13, 467–478. [Google Scholar] [CrossRef]
- Lavingnac, N.; Allender, C.J.; Brain, K.R. Current status of molecularly imprinted polymers as alternatives to antibodies in sorbent assays. Anal. Chim. Acta 2004, 510, 139–145. [Google Scholar] [CrossRef]
- Pichon, V.; Chappuis-Hugon, F. Role of molecularly imprinted polymers for selective determination of environmental pollutants—A review. Anal. Chim. Acta 2008, 622, 48–61. [Google Scholar] [CrossRef]
- Mairal, T.; Özalp, V.C.; Sánchez, P.L.; Mir, M.; Katakis, I.; O’Sullivan, C.K. Aptamers: Molecular tools for analytical applications. Anal. Bioanal. Chem. 2008, 390, 989–1007. [Google Scholar] [CrossRef]
- Zhou, J.; Battig, M.R.; Wang, Y. Aptamer-based molecular recognition for biosensor development. Anal. Bioanal. Chem. 2010, 398, 2471–2480. [Google Scholar] [CrossRef]
- Velasco-Garcia, M.N.; Missailidis, S. New trends in aptamer-based electrochemical biosensors. Gene Ther. Mol. Biol. 2009, 13, 1–10. [Google Scholar]
- Tombelli, S.; Mascini, M. Aptamers as molecular tools for bioanalytical methods. Curr. Opin. Mol. Ther. 2009, 11, 179–188. [Google Scholar]
- Tombelli, S.; Mascini, M. Aptamers biosensors for pharmaceutical compounds. Combinat. Chem. High Throughput Screen. 2010, 13, 641–649. [Google Scholar]
- Houwen, F.P.; Kage, A. Aptamers: The chemical antbodies. In Antibodies: Applications and New Developments; Meulenberg, E.P., Ed.; Bentham eBooks: Bussum, The Netherlands, 2012; pp. 300–314. [Google Scholar]
- Sassolas, A.; Blum, L.J.; Leca-Bouvier, B.D. Homogeneous assays using aptamers. Analyst 2011, 136, 257–274. [Google Scholar] [CrossRef]
- Wang, R.E.; Zhang, Y.; Cai, J.; Cai, W.; Gao, T. Aptamer-based fluorescent biosensors. Curr. Med. Chem. 2011, 18, 1–10. [Google Scholar] [CrossRef]
- Wang, L.; Chen, W.; Ma, W.; Liu, L.; Ma, W.; Zhao, Y.; Zhu, Y.; Xu, L.; Kuang, H.; Xu, C. Fluorescent strip sensor for rapid determination of toxins. Chem. Commun. 2011, 47, 1574–1576. [Google Scholar]
- Cruz-Aguado, J.A.; Penner, G. Determination of ochratoxin A with a DNA aptamer. J. Agric. Food Chem. 2008, 56, 10456–10461. [Google Scholar] [CrossRef]
- Barthelmebs, L.; Jonca, J.; Hayat, A.; Prieto-Simon, B.; Marty, J.L. Enzyme-linked aptamer assays (ELAAs), based on a competition format for a rapid and sensitive detection of ochratoxin A in wine. Food Control 2011, 22, 737–743. [Google Scholar] [CrossRef]
- Kuang, H.; Chen, W.; Xu, D.; Xu, L.; Zhu, Y.; Liu, L.; Chu, H.; Peng, C.; Xu, C.; Chu, S. Fabricated aptamer-based electrochemical “signal-off” sensor of ochratoxin A. Biosensors Bioelectr. 2010, 26, 710–716. [Google Scholar] [CrossRef]
- Bonel, L.; Vidal, J.C.; Duato, P.; Castillo, J.R. An electrochemical competitive biosensor for ochratoxin A based on a DNA biotinylated aptamer. Biosensors Bioelectr. 2011, 26, 3254–3259. [Google Scholar] [CrossRef]
- Tong, P.; Zhang, L.; Xu, J.J.; Chen, H.Y. Simply amplified electrochemical aptasensor of ochratoxin A based on exonuclease-catalyzed target recycling. Biosensors Bioelectr. 2011, 29, 97–101. [Google Scholar] [CrossRef]
- Yang, C.; Wang, Y.; Marty, J.L.; Yang, X. Aptamer-based colorimetric biosensing of ochratoxin A using unmodified gold nanoparticles indicator. Biosensors Bioelectr. 2011, 26, 2724–2727. [Google Scholar] [CrossRef]
- Yang, C.; Lates, V.; Prieto-Simón, B.; Marty, J.L.; Yang, X. Aptamer-DNAzyme hairpins for biosensing of ochratoxin A. Biosensors Bioelectr. 2012, 32, 208–212. [Google Scholar] [CrossRef]
- Lobeau, M.; de Saeger, S.; Sibanda, L.; Barna-Vetró, I.; van Peteghem, C. Development of a new clean-up tandem assay column for the detection of ochratoxin A in roasted coffee. Anal. Chim. Acta 2005, 538, 57–61. [Google Scholar] [CrossRef]
- Goryacheva, I.Y.; de Saeger, S.; Lobeau, M.; Eremin, S.A.; Barna-Vetró, I.; van Peteghem, C. Approach for ochratoxin A fast screening in spices using clean-up tandem immunoassay columns with confirmation by high performance liquid chromatography—tandem mass spectrometry (HPLC-MS/MS). Anal. Chim. Acta 2006, 577, 38–45. [Google Scholar] [CrossRef]
- Goryacheva, I.Y.; de Saeger, S.; Nesterenko, I.S.; Eremin, S.A.; van Peteghem, C. Rapid all-in-one three-step immunoassay for non-instrumental detection of ochratoxin A in high-coloured herbs and spices. Talanta 2007, 72, 1230–1234. [Google Scholar] [CrossRef]
- Rusanova, T.Y.; Beloglazova, N.V.; Goryacheva, I.Y.; Lobeau, M.; van Peteghem, C.; de Saeger, S. Non-instrumental immunochemical tests for rapid ochratoxin A detection in red wine. Anal. Chim. Acta 2009, 653, 97–102. [Google Scholar] [CrossRef]
- Beloglazova, N.V.; Goryacheva, I.Y.; Rusanova, T.Y.; Yurasov, N.A.; Galve, R.; Marco, M.P.; de Saeger, S. Gel-based immunotest for simultaneous detection of 2,4,6-trichlorophenol and ochratoxin A in red wine. Anal. Chim. Acta 2010, 672, 3–8. [Google Scholar] [CrossRef]
- Goryacheva, I.Y.; Rusanova, T.Y.; Beloglazova, N.V.; Voronov, I.I.; de Saeger, S. Determination of ochratoxin A in colored food products: Sample preparation and an immunoassay test method. J. Anal. Chem. 2010, 65, 760–766. [Google Scholar] [CrossRef]
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).


- Is hair analysis accurate for heavy metals?
- How common are hair drug tests?
- What are the three major types of hair analysis?
- How accurate is alcohol hair test?
- What hair analysis can reveal?
- What if hair is too short for drug test?
- When was hair analysis first used?
- How much alcohol does it take to show up in a hair test?
- Does CBD show up on hair follicle drug test?
- Are hair sample allergy tests accurate?
- Will I fail a drug test if I drank the night before?
- How do you get tested for heavy metals?
- What is hair tissue mineral analysis?
- Is hair analysis really accurate?
- Can hair be used as DNA evidence?
- Will one beer show up on a pee test?
- Can a hair test detect one time use?
Is hair analysis accurate for heavy metals?
The authors concluded that hair analysis is unreliable.
From an analytical point of view, hair analysis is not a robust diagnostic tool for heavy metal poisoning.
The specimen is prone to exogenous contamination because hair is a perfect binding medium for dust..
How common are hair drug tests?
Urine, which is by far the most prevalent, with 90 percent of employers using it, according to background screening firm HireRight. Saliva, used by 10 percent of employers. Hair, used by 7 percent of employers.
What are the three major types of hair analysis?
Forensic scientists perform 3 major types of hair analysis: (1) testing the hair shaft for drugs or nutritional deficiencies in a person’s system, (2) analyzing DNA collected from the root of the hair, and (3) viewing hair under a microscope to determine if it’s from a particular person or animal.
How accurate is alcohol hair test?
Results: EtG was detected in 29 out of 100 hair samples. Based on the Society of Hair Testing (SOHT) threshold of 30 pg/mg EtG, the hair test identified alcohol consumption in 57.9% of high-risk drinkers, 45.5% of increasing-risk drinkers and only 9.8% of lower-risk drinkers.
What hair analysis can reveal?
You can’t wash them out. Because of that, your hair can reveal if you’ve been using drugs like opioids, cocaine, amphetamines, and cannabis. While a urine test will reveal if you’ve used drugs in the last several days, hair testing can show if you’ve done drugs over the past 3 months.
What if hair is too short for drug test?
When someone has short hair, the sample can still be collected, it just has to cover a larger portion of the head. If a person is bald or has a shaved head, a body hair sample can be collected. If the person being tested has no hair on their body, a hair drug test cannot be administered.
When was hair analysis first used?
1855Hair is an obvious source of trace evidence in many crime scenes as it is frequently shed and easily transferred to clothes, sheets or carpets, or from one person to another. The first use of forensic hair analysis occurred in 1855 during the murder trial of John Browning.
How much alcohol does it take to show up in a hair test?
In hair, the three different EtG thresholds for a positive test were: 30 pg/mg, which according to the Society of Hair Testing strongly suggests chronic excessive alcohol use 25; a USDTL laboratory standard of 20 pg/mg; and 8 pg/mg, the limit of quantitation.
Does CBD show up on hair follicle drug test?
Cannabidiol (CBD) shouldn’t show up on a drug test. However, many CBD products contain trace amounts of delta-9-tetrahydrocannabinol (THC), marijuana’s main active ingredient.
Are hair sample allergy tests accurate?
There’s no evidence that this can help diagnose a food allergy. In addition, hair samples don’t contain IgE. Keep in mind that food allergies can be serious. It’s best to make sure you get an accurate diagnosis from a doctor to avoid potentially life-threatening reactions.
Will I fail a drug test if I drank the night before?
It is possible for your system to still have enough alcohol in it the next morning that you could fail a urine or blood test for driving under the influence. You would definitely have a problem trying to pass a test that is designed to detect the presence of any alcohol.
How do you get tested for heavy metals?
Doctors can usually check for heavy metal poisoning with a simple blood test known as a heavy metals panel or heavy metal toxicity test. To do the test, they’ll take a small blood sample and test it for signs of heavy metals.
What is hair tissue mineral analysis?
What Is Hair Tissue Mineral Analysis (HTMA) HTMA is a safe and non-invasive pathology test. It measures the levels and comparative ratios of nutrient and toxic minerals found in hair. HTMA is one of the most valuable screening tools available in preventative health care.
Is hair analysis really accurate?
But hair analysis is not a accurate way of determining your need for vitamins, minerals, or other nutrients. The importance of most of the findings from hair analysis is unclear. It is hard to interpret a hair analysis for the presence of heavy metals without other testing.
Can hair be used as DNA evidence?
Although hair is routinely collected at the scene of a crime, these days it is considered unreliable and rarely used as forensic evidence – especially after the FBI acknowledged that its testimony on microscopic hair analysis was flawed in at least 90% of cases.
Will one beer show up on a pee test?
The average urine test can detect alcohol between 12 and 48 hours after drinking. More advanced testing can measure alcohol in the urine 80 hours after you drink. Breath tests for alcohol can detect alcohol within a shorter time frame. This is about 24 hours on average.
Can a hair test detect one time use?
A further consideration with respect to hair testing is the sensitivity of the test. The test will not detect single use of a drug.


The sugars streptose and dihydrohydroxystreptose (DHHS) are unique to the bacteria Streptomyces griseus and Coxiella burnetii respectively. Streptose forms the central moiety of the antibiotic streptomycin, whilst DHHS is found in the O-antigen of the zoonotic pathogen C. burnetii. Biosynthesis of these sugars has been proposed to follow a similar path to that of TDP-rhamnose, catalysed by the enzymes RmlA/RmlB/RmlC/RmlD. Streptose and DHHS biosynthesis unusually require a ring contraction step that might be performed by the orthologues of RmlC or RmlD. Genome sequencing of S. griseus and C. burnetii proposed the StrM and CBU1838 proteins respectively as RmlC orthologues. Here, we demonstrate through both coupled and direct observation studies that both enzymes can perform the RmlC 3,5 double epimerisation activity; and that this activity supports TDP-rhamnose biosynthesis in vivo. We demonstrate that proton exchange is faster at the 3 position than the 5 position, in contrast to a previously studied orthologue. We solved the crystal structures of CBU1838 and StrM in complex with TDP and show that they form an active site highly similar to previously characterised enzymes. These results further support the hypothesis that streptose and DHHS are biosynthesised using the TDP pathway and are consistent with the ring contraction step being performed on a double epimerised substrate, most likely by the RmlD paralogue. This work will support the determination of the full pathways for streptose and DHHS biosynthesis.


Applications are invited for PhD studentships, starting in September/October 2019.
These are full-time, fully-funded, covering tuition fees at the home rate plus a stipend (currently £14,777 per annum). Unless otherwise stated, studentships are for three years.
The projects currently available are listed below. Additional projects may become available, so please keep checking for further details.
Academic criteria - a minimum of 2.1 honours in a relevant subject. Candidates with a 2.2 honours degree and a suitable MSc may also be considered.
Residency criteria – unless otherwise stated, only UK residents, as defined by the University’s Postgraduate Office, are eligible to apply. This is because of funding body constraints.
How to apply
Applications must be submitted online at: http://go.qub.ac.uk/pgapply. Only applications submitted via the online portal will be accepted.
The closing date is 1 April 2019.
For general enquiries, including queries about the application process, contact the School Research Office (firstname.lastname@example.org) in the first instance. For more detailed information about the projects, contact the named supervisor. For queries about eligibility, contact the University’s Postgraduate Office (email@example.com)
Available projects (as at 11 March 2019)
Developing a New Method for Monitoring the Kinetics of Homogeneously Catalysed Reactions (Supervisor: Dr Paul Dingwall)
Traditional methods of monitoring reactions over time involve either specialised and expensive instruments to collect in situ data (FTIR, calorimetry) or time-consuming, and occasionally technically challenging, collection of samples followed by offline sample analysis. This interdisciplinary project will involve the construction of equipment, as well as control software, to demonstrate proof of principle for a novel method to rapidly monitor the kinetics of homogeneous reactions, with a focus on homogeneous catalysis. The candidate will develop expertise in physical organic chemistry, homogeneous catalysis, python coding, flow chemistry, synthetic organic chemistry and a range of analytical techniques (HPLC, LCMS, NMR, etc).
Interested students should contact Dr Dingwall to discuss the position in more detail.
Copper-based electrocatalysts for energy applications (supervisor: Dr Paul Kavanagh)
The primary aim of this fully funded DfE project is to develop novel electrocatalysts, composed of Earth abundant elements, for the efficient electrochemical oxidation of sustainable fuels e.g. alcohols, glycerol and carbohydrates. Copper nitroxyl-based electrocatalysts, inspired by the active sites of alcohol oxidising metalloenzymes, have recently emerged as viable alcohol oxidising catalysts for the scalable synthesis of fine chemicals. It has yet to be investigated, though, if such catalysts can be adapted for oxidation of alcohol based fuels for electrochemical energy conversion. This project will examine a series of structurally related copper nitroxyl complexes as redox mediators for the oxidation of alcohol-based fuels. A strong emphasis will be placed on unravelling the underlying reaction mechanism, which, to date, is largely unknown. Insights gained from this will permit rational enhancement of catalyst activity, through electronic and structural tuning, and optimisation of reaction conditions. Ideal PhD candidates should have a strong interest in metal-ligand coordination chemistry with the ability to develop new skills in electrochemical analysis.
Interested students should contact Dr Paul Kavanagh (firstname.lastname@example.org) to discuss the position in more detail.
Foldamer Therapeutics for Amyloid Disease (supervisors: Dr Peter Knipe and Dr Stephen Cochrane)
Foldamers are artificial oligomeric molecules that mimic the structural and functional properties of natural biopolymers such as peptides. We recently developed an entirely new foldamer capable of adopting protein-like tertiary structures in predictable, sequence-defined manner (ACIE 2018, 57, 8478), and have recently formed the cyclic analogues of these foldamers.
Many neurodegenerative conditions including Alzheimer’s, Parkinson’s and Huntington’s diseases involve misfolding and aggregation of peptides, followed by their deposition as insoluble amyloid plaques. This project will explore the use of novel cyclic (and acyclic) foldamers as potential therapeutics for neurodegeneration by targeting amyloid formation and growth, in collaboration with Dr Jinghui Luo (Paul Scherrer Institut).
The student will develop strong synthetic skills, and a detailed knowledge of advanced analytical techniques including multidimensional NMR, HPLC(MS), and GC, all of which are in high demand from employers in the chemical sector.
The project will involve the synthesis, characterization and testing of complex organic molecules, so candidates should have a strong background in synthetic organic chemistry or related areas.
Functionalized Biocompatible Block Copolymer Particles and Fibres Produced by Electrospraying/Electrospinning for Biomedical Applications (supervisor: Dr Efrosyni Themistou)
The design of novel biodegradable polymeric nano- and micro- structures containing functional groups is of high importance in the biomedical field, and especially in drug delivery and tissue engineering. Functionalization of polymers with reactive groups is highly desirable, since these groups can be used for attachment of biologically-important molecules on the polymers, such as antibodies, peptides and/or fluorescent dyes. The project will involve the preparation of novel biodegradable functionalized polymeric particles by eloctrospraying and fibres by electrospinning. Modern polymerisation techniques including reversible addition-fragmentation chain transfer (RAFT) polymerisation and ring opening polymerisation (ROP) will be used for the synthesis of a series of biocompatible biodegradable polymers with different functional groups. The student will receive training in various polymer characterisation techniques such as nuclear magnetic resonance (NMR) spectroscopy, gel permeation chromatography (GPC), dynamic light scattering (DLS) and scanning and transmission electron microscopy (SEM and TEM). The particles and fibres exhibiting favourable structural characteristics will be further assessed for their suitability in attachment of biologically-important molecules and their use in efficient drug delivery (encapsulation and release of anti-cancer drugs) and tissue engineering (attachment of stem cells), respectively. Applicants will have a degree in Chemistry, Materials Science, Chemical Engineering, Biomedical Science or a closely related subject and a strong interest and motivation in pursuing research in polymeric biomaterials. The project will be undertaken under the supervision of Dr Efrosyni Themistou and will involve the potential for the successful candidate to work in collaborator laboratories during their research project.
For further information, please contact email@example.com.
Main group catalysis with ionic liquids (supervisor: Dr Gosia Swadźba-Kwaśny and Dr John Holbrey)
A 3-year, fully funded PhD position is available starting September/October 2019 in the Swadźba-Kwaśny group, at the QUILL Research Centre. The project scope combines two topical areas: Main Group catalysis and ionic liquids. The aim is to further the development of new ionic liquids with highly Lewis acidic cations, for applications in catalysis, in particular in carbocationic processes and as frustrated Lewis pairs.
The project is suitable for an independent thinking, enthusiastic student, interested in a project spanning from synthetic inorganic chemistry, through physical chemistry (spectroscopic studies), to homogenous catalysis.
For further information, please contact firstname.lastname@example.org.
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11


Dow selected for desalination pilot project in UAE
US firm chosen by Degremont to work on energy efficient plant in Abu Dhabi.
Dow Water and Process Solutions has been selected by Degremont of France to supply its advanced membrane solutions for a desalination plant in Abu Dhabi, in partnership with Masdar.
The project is in management of the pilot desalination program launched by Masdar to test and develop energy-efficient seawater desalination technologies that can be supplied by renewable energy sources.
The pilot will call for a full-scale facility to be operational by 2020, with the long-term objective to implement the best performing technologies in desalination plants across the United Arab Emirates (UAE).
The 18-month pilot project will cover all facets of the design, implementation, and maintenance of a pilot desalination unit.
The plant, potentially powered completely by renewable energy sources, will offer more energy efficiency than current desalination systems and will be suitable for the seawater and environmental conditions found throughout the UAE.
Degremont has chosen Dow Water and Process Solutions due to the unique and innovative technology of its energy efficient advanced DOW Ultrafiltration and Reverse Osmosis membranes.
Remi Lantier, CEO of Degremont, said,: “We are excited to partner with Dow on the Renewable Energy Seawater Desalination Program. As a world leader in water treatment we take innovation to heart and Dow Water & Process Solutions consistently brings to market innovative reverse osmosis technologies.”
Technologies to be installed include DOW FILMTEC SEAMAXX, which can reduce energy consumption in desalination processes by up to 10%, compared to other Reverse Osmosis elements on the market, and DOW FILMTEC ECO elements, which offer unparalleled rejection and flow performance for industrial water needs whilst enabling up to 30% reduction in energy usage.
“Membrane technologies, like those found in DOW Ultrafiltration & DOW FILMTEC Reverse Osmosis elements, are far more energy efficient than the thermal processes currently used in most of the desalination plants throughout the UAE,” said Zakia Bahjou, MEA Regional Commercial Manager, Dow Water and Process Solutions.
“Dow is committed to bringing the latest water desalination technologies to the UAE, and is excited to be partnering with such companies as Masdar and Degremont to bring this project to life.”
With DOW Ultrafiltration and DOW FILMTEC Reverse Osmosis membrane technologies, Dow Water and Process Solutions will assist Degremont in demonstrating that solutions and technologies implemented in the pilot phase can decrease the energy consumption and increase the overall recovery of a sea water desalination system.


Structure of the N-linked oligosaccharide of the main diagnostic antigen of the pathogenic fungus Paracoccidioides brasiliensis.Glycobiology. 1996 Jul; 6(5):507-15.G
The major diagnostic antigen of Paracoccidioides brasiliensis is the exocellularly secreted 43,000 Da glycoprotein (gp43) which contains a single N-linked oligosaccharide chain. This oligosaccharide, although poorly immunogenic in man, is responsible for the cross-reactivity of the gp43 with sera from patients with histoplasmosis, and may have a role in fungal virulence. It contains a neutral high-mannose core (Man7GlcNAc2) to which a (1-->6)-linked alpha-D-Manp chain of variable length, substituted at the 2-O positions by single alpha-D-Manp residues, is attached. A terminal unit of beta-D-galactofuranose is (1-->6)-linked to one of the (1-->2)-linked mannosyl residues, either in the C or in the A arm of the oligosaccharide. The heterogeneity of the oligosaccharide is determined by the different sizes of the A arm and the sites of insertion of the beta-galactofuranosyl unit. The complete structure was determined by methylation analysis, 1H-NMR, mass spectrometry, acetolysis and mannosidase degradation. Electrospray mass spectrometry showed that the oligosaccharide comprises several subtypes ranging from Hex18GlcNAc2 to Hex10GlcNAc2 which accounts for the diffuse migration of the gp43 in polyacrylamide gels. The average size of the most frequent subtype is Hex13.6GlcNAc2. Dilute acid treatment to remove beta-D-Galf reduced the molecular masses of the majority of the subtypes by a single sugar unit.


Breast cancer continues to be a devastating disease in spite of targeted therapies against the estrogen receptor alpha (ER?), the progesterone receptor, and the human epidermal growth factor receptor-2 (Her2). Breast cancers lacking expression of all three receptors are named triple-negative breast cancer (TNBCs). TNBCs are hard to treat due to lack of targeted therapy. Over half of TNBCs overexpress EGFR. Recently our lab showed a NCI investigational drug aminoflavone (AF) exhibits strong cytotoxicity in TNBC cells with GC50 at nM range. AF induces DNA damage, cell cycle arrest and apoptosis in TNBC cell lines. Despite promising growth inhibitory effects, several human clinical trials on AF had been terminated due to systematic toxicity. Thus, there is a pressing need to develop multifunctional nanocarriers to encapsulate AF for targeted cancer therapy. In collaboration with Dr. Gong's group, we have recently designed a unique unimolecular micelle nanoparticle platform as AF nanocarrier for targeted TNBC therapy. We have promising preliminary data indicating that conjugation of an EGFR targeting peptide, GE11, to unimolecular micelles enhances the cellular uptake of the AF-loaded nanoparticles in EGFR-overexpressing TNBC cells. This application will further examine the specificity and efficacy of AF-loaded, GE11-conjugated unimolecular micelles in in vitro and in vivo models. The grant proposal includes two specific aims:
Aim 1 will test the specificity of AF-loaded, GE11-conjugated unimolecular micelles towards EGFR overexpressing vs. non-expressing triple negative breast cancer cells.
Aim 2 will determine the therapeutic efficacy and systemic toxicity of AF-loaded unimolecular micelles in various in vivo models. Collectively, our study will determine whether unimolecular micelles conjugated with an EGFR-recognizing peptide, i.e. GE11, allows for targeted delivery of AF to EGFR- overexpressing TNBC, minimizing systemic toxicity while improving therapeutic efficacy.
Triple Negative Breast cancer lacks expression of ER?, PR, and Her2, constitutes 15-20% of all breast cancer diagnosis. TNBC has the worst prognosis compared to other subtypes of breast cancer and non- targeted therapy is currently available. This study aims to develop a nanoparticle-based, aminoflavone (AF) drug delivery system that would increase tumor-targeting efficacy while circumventing the systemic toxicity associated with AF treatment.
|Chen, Guojun; Ma, Ben; Xie, Ruosen et al. (2018) NIR-induced spatiotemporally controlled gene silencing by upconversion nanoparticle-based siRNA nanocarrier. J Control Release 282:148-155|
|Chen, Guojun; Ma, Ben; Wang, Yuyuan et al. (2018) A Universal GSH-Responsive Nanoplatform for the Delivery of DNA, mRNA, and Cas9/sgRNA Ribonucleoprotein. ACS Appl Mater Interfaces 10:18515-18523|
|Chen, Guojun; Jaskula-Sztul, Renata; Esquibel, Corinne R et al. (2017) Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging. Adv Funct Mater 27:|
|Liu, Fabao; Ma, Fengfei; Wang, Yuyuan et al. (2017) PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis. Nat Cell Biol 19:1358-1370|
|Jaskula-Sztul, Renata; Chen, Guojun; Dammalapati, Ajitha et al. (2017) AB3-Loaded and Tumor-Targeted Unimolecular Micelles for Medullary Thyroid Cancer Treatment. J Mater Chem B 5:151-159|
|Wang, Yuyuan; Wang, Yidan; Chen, Guojun et al. (2017) Quantum-Dot-Based Theranostic Micelles Conjugated with an Anti-EGFR Nanobody for Triple-Negative Breast Cancer Therapy. ACS Appl Mater Interfaces 9:30297-30305|
|Chen, Guojun; Ma, Ben; Wang, Yuyuan et al. (2017) CuS-Based Theranostic Micelles for NIR-Controlled Combination Chemotherapy and Photothermal Therapy and Photoacoustic Imaging. ACS Appl Mater Interfaces 9:41700-41711|
|Shishkova, Evgenia; Zeng, Hao; Liu, Fabao et al. (2017) Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition. Nat Commun 8:15571|
|Wang, Yuyuan; Wang, Liwei; Chen, Guojun et al. (2017) Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy. Macromol Biosci 17:|
|Chen, Guojun; Wang, Yuyuan; Xie, Ruosen et al. (2017) Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery. J Control Release 259:105-114|
Showing the most recent 10 out of 12 publications


Double Cone Machines
Used Double Cone Equipment
A double cone powder mixer is actually two cones, one inverted into the other, to form the double cone with the mixer rotated about the widest portion of the top and bottom cones. The batch mixer is loaded from the top and the contents allowed to inter mix caused by the rotation of the mixer. Double cone powder mixers can also be jacketed and they can have an intensifier bar along the rotation axis to facilitate breakdown of clumpy materials. Double cone powder mixers can also have liquid addition nozzles along this rotation axis.